ErbB3 Human, sf9

Tyrosine Kinase ErbB-3 Human Recombinant, sf9
Cat. No.
BT16222
Source
Sf9, Baculovirus cells.
Synonyms
Tyrosine Kinase ErbB-3, sf9, ErbB3 sf9, Receptor tyrosine-protein kinase erbB-3, ERBB3, Proto-oncogene-like protein c-ErbB-3, Tyrosine kinase-type cell surface receptor HER3, HER3, Receptor tyrosine-protein kinase erbB-3 isoform, c-erbB-3, ErbB-3, erbB3-S, LCCS2, MDA-BF-1, p180-ErbB3, p45-sErbB3, p85-sErbB3.
Appearance
Sterile Filtered colorless solution.
Purity

Greater than 90.0% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

ErbB3 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 863 amino acids (20-643 a.a.) and having a molecular mass of 95.6kDa (Migrates at 100-150kDa on SDS-PAGE under reducing conditions).
ErbB3 is expressed with a 239 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
ErbB3, also known as Her3 (human epidermal growth factor receptor 3), is a type I membrane glycoprotein belonging to the ErbB family of tyrosine kinase receptors. These receptors bind to epidermal growth factor (EGF) family growth factors. ErbB3 is unique among ErbB family members due to its defective kinase domain. It is found in various cells, including keratinocytes, melanocytes, skeletal muscle cells, embryonic myoblasts, and Schwann cells. Monomeric ErbB3 acts as a low-affinity receptor for heregulins (HRG). Importantly, ErbB3 can trigger the production of specific antibodies in living organisms, offering a potential avenue for inhibiting tumor cell growth. ErbB-3 is explored as a treatment option for breast cancer cases with ErbB2 overexpression, encompassing early, medium, advanced, and post-operative stages. Based on its mode of action, ErbB3 is classified as a cancer therapeutic.
Description
Recombinant Human ErbB3, produced in Sf9 Baculovirus cells, is a single glycosylated polypeptide chain consisting of 863 amino acids (specifically, amino acids 20 to 643). It has a molecular weight of 95.6 kDa. On SDS-PAGE analysis under reducing conditions, it migrates between 100-150 kDa. The protein is expressed with a 239 amino acid hIgG-His tag at its C-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Clear, colorless solution that has been sterilized by filtration.
Formulation
The ErbB3 protein solution is provided at a concentration of 0.25 mg/ml. It is formulated in Phosphate Buffered Saline (pH 7.4) containing 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the entire vial can be stored at 4°C. For extended storage, freezing at -20°C is recommended. To ensure optimal stability during long-term storage, the addition of a carrier protein (either HSA or BSA) at a concentration of 0.1% is advised. It is important to avoid subjecting the solution to repeated freeze-thaw cycles.
Purity
The purity of the ErbB3 protein is determined to be greater than 90.0% using SDS-PAGE analysis.
Synonyms
Tyrosine Kinase ErbB-3, sf9, ErbB3 sf9, Receptor tyrosine-protein kinase erbB-3, ERBB3, Proto-oncogene-like protein c-ErbB-3, Tyrosine kinase-type cell surface receptor HER3, HER3, Receptor tyrosine-protein kinase erbB-3 isoform, c-erbB-3, ErbB-3, erbB3-S, LCCS2, MDA-BF-1, p180-ErbB3, p45-sErbB3, p85-sErbB3.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence
SEVGNSQAVC PGTLNGLSVT GDAENQYQTL YKLYERCEVV MGNLEIVLTG HNADLSFLQW IREVTGYVLV AMNEFSTLPL PNLRVVRGTQ VYDGKFAIFV MLNYNTNSSH ALRQLRLTQL TEILSGGVYI EKNDKLCHMD TIDWRDIVRD RDAEIVVKDN GRSCPPCHEV CKGRCWGPGS EDCQTLTKTI CAPQCNGHCF GPNPNQCCHD ECAGGCSGPQ DTDCFACRHF NDSGACVPRC PQPLVYNKLT FQLEPNPHTK YQYGGVCVAS CPHNFVVDQT SCVRACPPDK MEVDKNGLKM CEPCGGLCPK ACEGTGSGSR FQTVDSSNID GFVNCTKILG NLDFLITGLN GDPWHKIPAL DPEKLNVFRT VREITGYLNI QSWPPHMHNF SVFSNLTTIG GRSLYNRGFS LLIMKNLNVT SLGFRSLKEI SAGRIYISAN RQLCYHHSLN WTKVLRGPTE ERLDIKHNRP RRDCVAEGKV CDPLCSSGGC WGPGPGQCLS CRNYSRGGVC VTHCNFLNGE PREFAHEAEC FSCHPECQPM EGTATCNGSG SDTCAQCAHF RDGPHCVSSC PHGVLGAKGP IYKYPDVQNE CRPCHENCTQ GCKGPELQDC LGQTLVLIGK THLTRSPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGKHHH HHH.

Product Science Overview

Introduction

Tyrosine Kinase ErbB-3, also known as HER3 (human epidermal growth factor receptor 3), is a member of the ErbB family of receptor tyrosine kinases. This family includes other well-known receptors such as EGFR (ErbB1), HER2 (ErbB2), and ErbB4. ErbB-3 is unique among its family members due to its defective kinase domain, which means it lacks intrinsic kinase activity and relies on dimerization with other ErbB receptors to activate downstream signaling pathways .

Structure and Function

ErbB-3 is a type I membrane glycoprotein that consists of an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular domain. The extracellular domain contains four subdomains (I-IV), with subdomains I and III primarily involved in ligand binding, while subdomains II and IV contribute to protein conformation and stability .

Despite its defective kinase domain, ErbB-3 plays a crucial role in cellular signaling. It can form heterodimers with other ErbB family members, particularly ErbB-2 (HER2), to initiate signal transduction. Ligand binding, such as with heregulins (HRG), induces a conformational change in ErbB-3 that allows for dimerization, phosphorylation, and activation of downstream signaling pathways .

Expression and Role in Cancer

ErbB-3 is expressed in various tissues, including keratinocytes, melanocytes, skeletal muscle cells, embryonic myoblasts, and Schwann cells . Its expression is also observed in several types of cancer, where it can contribute to tumor growth and progression. Overexpression of ErbB-3 has been linked to breast cancer, and it is considered a therapeutic target for cancer treatment .

Human Recombinant ErbB-3 (sf9)

The human recombinant ErbB-3 protein produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 863 amino acids. It has a molecular mass of approximately 95.6 kDa and is expressed with a 239 amino acid hIgG-His tag at the C-terminus. This recombinant protein is purified using proprietary chromatographic techniques and is available in various quantities for research purposes .

The recombinant ErbB-3 protein is used in various research applications, including studying its role in cancer, developing therapeutic antibodies, and understanding its signaling mechanisms. It is formulated in a phosphate-buffered saline solution with 10% glycerol and should be stored at 4°C for short-term use or frozen at -20°C for long-term storage .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.